Antiarrhythmic effectiveness of alprenolol, a new beta adrenergic receptor blocking agent.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000498:Allyl Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000605:Amino Alcohols / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D010636:Phenols / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D013565:Sympatholytics / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000498:Allyl Compounds; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D010636:Phenols; D010919:Placebos; D013565:Sympatholytics